Products Rifabutin is commercially available in capsule form (mycobutin). It has been approved in many countries since 1994. Structure and properties Rifabutin (C46H62N4O11, Mr = 847 g/mol ) is a semisynthetic ansamycin antibiotic. It exists as a reddish purple amorphous powder that is sparingly soluble in water. Effects Rifabutin (ATC J04AB04) has antibacterial properties against … Rifabutin
Products Rifampicin is commercially available as film-coated tablets, coated tablets, capsules, and injectables (Rimactan, generics). In addition to mono, various combination preparations are also available. Rifampicin has been approved in many countries since 1968. This article refers to peroral monotherapy. Structure and properties Rifampicin (C43H58N4O12, Mr = 823 g/mol) exists as a reddish brown to … Rifampicin
Products Rifamycin is commercially available in the form of ear drops (Otofa). It has been approved in many countries since 1988. Structure and properties Rifamycin (Rifamycin SV) is present in the drug as rifamycin sodium, a fine or slightly granular red powder that is soluble in water (C37H46NNaO12, Mr = 720 g/mol). It is obtained … Rifamycin
Products Rifaximin is commercially available in the form of film-coated tablets (Xifaxan). It was approved in many countries in 2015. In many countries, it was available earlier. Rifaximin was first released in Italy in the 1980s. Structure and properties Rifaximin (C43H51N3O11, Mr = 785.9 g/mol) is a semisynthetic pyridoimidazole derivative of rifamycin. It exists as … Rifaximin
